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Background: Mobile devices are increasingly being used for data collection in research. However, many researchers
do not have experience in collecting data electronically. Hence, the purpose of this short report was to identify
issues that emerged in a study that incorporated electronic capture of patient-reported outcomes in clinical
settings, and strategies used to address the issues.
Findings: The issues pertaining to electronic patient-reported outcome data collection were captured qualitatively
during a study on use of electronic patient-reported outcomes in two home dialysis units. Fifty-six patients
completed three surveys on tablet computers, including the Kidney Disease Quality of Life-36, the Edmonton
Symptom Assessment Scale, and a satisfaction measure. Issues that arose throughout the research process were
recorded during ethics reviews, implementation process, and data collection. Four core issues emerged including
logistics of technology, security, institutional and financial support, and electronic design.
Conclusions: Although use of mobile devices for data collection has many benefits, it also poses new challenges
for researchers. Advance consideration of possible issues that emerge in the process, and strategies that can help
address these issues, may prevent disruption and enhance validity of findings.
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Electronic capture of patient-reported outcomes (ePROs)
data [1-4], offers new opportunities to both re-
searchers and clinicians. The benefits and challenges
of ePROs previously addressed in the literature [1-16]
are summarized in the below list. Although guidelines
for reporting patient-reported outcomes have been
established [13,17-19], utilization of ePROs is a more
recent development. Over the past decade, researchers
have described how they worked with electronic data
collection systems, platforms or registries of ePROs
[3,4,6,11,12,15,16,20]. However, pragmatic issues and
potential strategies that a researcher might use when
conducting a study to collect ePRO data are not often
discussed, and this paper addresses this gap in the
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article, unless otherwise stated.Benefits and challenges of administering ePROs
Benefits
Immediate access to retrievable data [1,6]
Potential to link ePRO data with electronic
health records [6,12,13]
Capacity to trigger automated alerts when patients
identify problems [1,3,6,11-13]
Immediate scoring and presentation of data [2,5-7,12]
More economical in terms of resources and time
[3,4,6-8,12,15]
Greater likelihood of reporting sensitive
information [1,2,5]
Prevention of errors in data-entry [1,4]
Observation of survey completion in real-time [1,5,6,11]
Improved data quality [3,4]
Less missing information [1,2,8,12]
With minor modifications from paper to electronic
formats, validation is not likely necessary [1,6,7,9]
Patient satisfaction with electronic platform [1,2,5,7,11,14]
Storage of longitudinal data [2,12]BioMed Central. This is an Open Access article distributed under the terms of
tp://creativecommons.org/licenses/by/4.0), which permits unrestricted use,
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locations (ie home, clinic etc.) [2,6,12,15,16]
Enhanced communication and effectiveness of
multidisciplinary care [3,6,11]
ePRO data can be collected independently from
encounters with healthcare providers [6,11]
Educational materials for patients can be tailored to
their scores [5,6,11]
Challenges
Greater expense and upfront planning compared to
paper administration [1,6,12]
Necessity of training of clinical staff, researchers or
patients [1,6]
Resistance in a healthcare culture to electronic
administration [1]
Inadequate information technology structures in
research sites (ie computers or mobile devices,
personnel, secure servers) [1,12]
Instruction and supervision may be required by people
with limited computer experience [12,14]
May encounter challenges linking ePRO data to patient
health records or other datasets [3,5,6]
Integrating ePRO data into clinic workflow and
interpretation of clinical relevance [6]
Purpose and research question
The purpose of this research was to identify issues that
emerged in a study that incorporated ePROs in clinical
settings and to identify possible solutions/strategies to
address the issues.
Methods
The overall focus of the pilot project was the feasibility
of using tablet computers to collect ePROs in two out-
patient dialysis clinics [14]. People attending a clinic, in
one of two cities in Western Canada, were invited to
participate if they were over 19 years old, did not have
mild-severe cognitive challenges, could speak and read
English, and were medically stable. Fifty-six dialysis pa-
tients volunteered. They were primarily older adults with
a mean age of 66 ± 12 (36–91 years old), and only two
had used a tablet computer previously. Ethics approval
was attained from a University Human Research Ethics
Board and a health authority. While in the clinic waiting
room, participants completed two ePROs (Kidney Disease
Quality of Life-36 ((KDQOL-36)) [21]), and Edmonton
Symptom Assessment Scale ((ESAS)) [22]) and a patient
satisfaction measure. The tablet computer used in this
study was the iPad™ (iPad is a trademark of Apple, Inc).
The ESAS was designed as a new application (app), and
the KDQOL-36 was completed through KDQOL Complete
[23] providing online scores in real time. The ESAS apphad minor modifications, and measurement equivalence
was addressed through cognitive debriefing and usability
testing [9,14].
Interpretive description, an established qualitative meth-
odology used in applied clinical fields, is an inductive
approach that offers ways to consider themes/patterns
from subjective descriptions, and create descriptions that
inform clinical understanding [24]. It was used to identify
the core ePRO issues that arose and strategies that were
used during the design and conduct of the project. The re-
searchers qualitatively recorded issues that arose during
ethics reviews and data collection. Researchers used field
notes and emails to each other to formally document the
issues. Notes were updated when issues were resolved and
new matters arose [24,25]. Analysis was undertaken at a
conceptual/thematic descriptive level, identifying thematic
patterns developed in situ from the data [25]. If another
researcher wanted to examine and verify our decision-
making and interpretation of findings in the interests of
rigor, audit trails (documentation and reflexive writing)
were created throughout the analytic process.Results
The themes that emerged relating to issues and strat-
egies to address ePRO implementation included: logistics
of technology, security, support, and design. Table 1 pro-
vides excerpts from field notes to support these themes.
The logistics for use of the technology in the clinical en-
vironment required considerable time and attention. In
our study, the health authority did not allow researchers
to access the healthcare institution’s intranet, and be-
cause one survey was conducted online, tablets needed
to have 3G (cellular) capacity. Given that health settings
often have variable cellular receptivity, the tablets
needed to be tested in various clinical locations. In this
project, it was not possible to synchronize ePRO and
electronic health data because the clinics were using a
hybrid of paper and electronic records. Logistical
issues arose due to the need for wireless printing.
Because clinicians requested that ePRO results be
printed for their use in real time, printing options re-
quired advance onsite testing.
Health administrators, practitioners, and patients all
asked about how infection control was being managed
with the tablet. We used two approaches. First, partici-
pants were asked to use a hand sanitizer. Second, every-
one used a stylus to prevent touching the screen. Older
adults who had not used a touch-screen tablet previously
found the stylus very helpful.
Technology security was paramount, and it came under
scrutiny during ethics reviews. While KDQOL-36 and
ESAS data was printed for clinicians, raw data was
downloaded daily to the university data repository so
Table 1 Findings and checklist
Theme Excerpt from field notes to support thematic findings Checklist for ePRO use in clinical settings
Logistics of
technology
Started brainstorming ideas to deal with how I am attending to infection
control: sanitizing screen? Using stylus? Hand sanitizer before hand
(and give to participant as a gift)? Disposable screen covers? Others?
I also want to talk [electronic provider] to see if they have other suggestions.
Have you attended to infection control?
Found out today that [health authority] has not formulated a strategy for
patient wireless access and requires staff members to have individual
accountability for their access. As a researcher, I am neither “patient” nor
“staff”. [Information Technology] confirmed that I cannot access their
internet. Alternative option is to use 3G [3rd generation of mobile
telephone/cellular technology].
Do you have access to the internet in the hospital/clinic/
health authority?
Advised to test iPad’s 3G connections in both home dialysis clinics. Hospital
building structures and medical equipment could interfere with 3G signal.
Have you tested the tablet in the clinical setting?
We decided to set up a new contract for one of the iPads with [a different
cellular provider] because in [2nd city], they have a tower nearby. Patients
from [2nd city] have told me that they have better reception with this
provider.
Using 3G will obviously have implications for printing – cannot print from
iPad without internet. I need to contact [computer programmer] about
purchasing router to connect iPad to printer - but without using internet
signal.
Do you need to print from the tablets?
The renal services are in the process of moving from paper to electronic
charting. But they aren’t there yet. In consultation with the nurses, they said
they want results printed and given to them on paper.
Do you need to access or synch with electronic health
records?
Security [Privacy analyst] told me I need a minimum of 8 characters for the
passwords on the iPads. Need to change all passwords on all iPads
accordingly.
Do you have your tablets password protected and
encrypted?
[Health authority] wants to know if devices will be dedicated to research
use, or if they will be brought in as-needed. Definitely dedicated for research
use only – will follow up with [research assistants] when they sign confiden-
tiality agreements too.
Although the iPads will be securely stored in my locked office when they
aren’t in use in the hospitals, we need to also have them securely stored on
the days they are used for data collection. In consultation with [research
assistant], we are going to buy a small box that locks and is on wheels (for
easy transport of equipment and files). We’ll keep the iPads locked in the
box when a patient is not using them.
Where will you securely store your tablets?
To meet [health authority] ethics standards, we need to back up all data on
Health Research Data Repository [HRDR; at University of Alberta] at the end
of every day of data collection.
Where are you storing your data?
Must receive confirmation of data transfer from HRDR before deleting data
off of iPads.
Are you frequently backing up your data?
Support [Health authority] has a requirement, as mandated by the Ministry of Health
and the OIPC [Office of the Information and Privacy Commissioner], to
encrypt all mobile devices used in their facilities. Need to provide proof that
the encryption is enabled on tablets.
Do you have support/approval from the Information
Management/Information Technology department in the
health setting?
[The nurse clinician] agreed that the ward clerk can ask patients, when she
calls them to remind them of their appointment, that if they are planning to
participate in the study, they need to come 15 minutes early – which is
fabulous! If patients are late, they will not be invited to participate. Data
collection is so different when it is happening “in real time” in a clinic
setting.
Requested approval to buy another iPad. With 3 research assistants in the
clinic each day, there are times when they all could be using one with a
patient. As it is now, sometimes they are waiting for a tablet, and more than
anything else, we can’t interrupt the flow of the clinic.
Do you have financial and technological support for
tablet development?
Need to start to set up invoice with KDQOL Complete prior to data
collection so I can trial data entry onsite.
Design Met with [academic professor] who is using iPads with healthcare
professionals. Even though they are assuming many participants will know
Do you need to adapt the screen display for a specific
population?
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Table 1 Findings and checklist (Continued)
how to use tablets, they are still opting to go with a very simple layout with
drop-down menu bars. The simpler, the better.
Read an article on computer use with seniors. They recommended using
large font, black writing on white/plain background, and no distracting
images on the screens. So definitely no pop-ups or flashing stars when a
survey is completed.
Met with [computer programmer] and he is using FileMaker Go to design
the app. We’ll meet at each phase to test and revise the design. And when
we are done, he’s going to provide a step-by-step set of instructions (with
pictures) for use of the app, download, and transfers.
Are you creating new apps to collect research data?
If yes, are you using data input time stamps?
Time stamps will be date/minute/second. In this way, they can also be used
as a back-up, secondary participant identifier because I’ll know the order of
participants who volunteered on any given day at the home dialysis clinics.
Coons et al. [9] – need to undertake cognitive debriefing and usability
testing to assess clarity, understanding, and usability of the technology. I
think I would like to include brief interviews with each participant after they
use the iPad.
Have you attended to measurement equivalence of the
electronic versus paper formats?
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file transfer protocol was required.
KDQOL-36 data was stored on the KDQOL Complete
database, housed on a US server. Under the US Patriot
Act, the US Government could access this data without
knowledge/consent by researchers or participants. To
uphold confidentiality, ID codes were used to identify
participants and this was explained in the informed con-
sent forms.
To ensure tablets were securely stored, they were kept
in a locked cabinet in the researcher’s office when not
being used. When being used, they were either with the
researcher or kept in a locked storage container. To
meet university/health authority ethical requirements,
tablet computers needed 8-digit passwords and the high-
est levels of encryption.
Institutional and financial support was essential. Eth-
ical review for the pilot project took approximately one
year, primarily due to the novelty of the technology in
the clinical setting. Approval was needed from the health
authority’s Information Technology department to en-
sure that their security requirements were met and
health privacy legislation was followed. Financial support
was necessary to assist with purchasing tablets and
printers, hiring computer programmers, procuring on-
line survey support, and accessing cellular internet.
Elements of electronic design were issues that emerged
in relation to the screen display, creation of new apps,
and measurement equivalence. Because participants were
primarily older adults without computer experience,
screen displays that were easily readable were needed. We
kept the app minimalistic with large font, black writing on
white background, and no distracting graphics. Time
stamps were also used to log data input as an audit trail.
Given that both the ESAS and KDQOL-36 were originally
designed for paper, there was a need for only minor modi-
fication of the instruments for the tablet [9].Discussion
This study offers strategies that researchers/practitioners
might consider useful when employing ePROs, a topic
rarely discussed in the literature. The findings are pre-
sented in Table 1 along with a checklist of questions that
researchers may ask themselves when using ePROs in
clinical settings.
Given that every clinical application of ePROs will be
unique, different issues may emerge in diverse contexts,
and testing in real-world conditions is imperative [4].
For example, technology logistics in clinical environ-
ments may dictate the capacity to which ePRO data may
be linked to electronic health records. In light of the
current expansion of organizations incorporating elec-
tronic patient records, combined with the desire for im-
mediate retrieval of electronic data, the potential to
integrate ePROs with electronic records will only con-
tinue to expand [1,6,12,13]. Strategies for such integra-
tion will be paramount as researchers strive for utility of
ePROs in clinical practice.
Specific clinical settings may also direct logistics con-
trolling the spread of infection. Strategies other than
those used in this study could include sanitizing the tab-
let screen between each use or using disposable screen
covers.
Institutional requirements regarding technology security
will vary based on national/local policies and contexts.
Specifically, passwords and encryption requirements will
differ in various healthcare settings. Documentation of se-
curity features is an important consideration, especially
during research ethics applications. Only two authors
[4,12] mentioned security requirements in the ePRO lit-
erature. However, in our project, this was a significant
consideration, one that required collaborative strategies
with computer programmers/privacy analysts.
Findings from this study regarding institutional and fi-
nancial support are substantiated in the literature. While
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greater upfront costs and training for patients/profes-
sionals to use technology, electronic formats are still
more economical both in terms of time and resources
[3,4,6-8,12,15]. ePROs also offer an environmental, paper-
less option. Despite international movement towards use
of ePROs for the purposes of creating retrievable data
[1,6], linking with electronic records [6,12,13], and trigger-
ing automated patient alerts [1,3,6,11-13], institutional
support was not recognized in the ePRO literature as a
critical strategy with the exception of acknowledging sup-
port from clinical leaders [4,6]. Research addressing how
ePRO data is used as a feedback mechanism to clinicians
is an area in need of future development.
Health data privacy requirements will vary based on the
legislation, policy, culture or health authority. Establishing
early collaborations with local Information Technology
departments may assist researchers to overcome chal-
lenges with institutional support.
The aspect of electronic design was rarely discussed,
with a few exceptions [6,15]. Our findings emphasize the
need to tailor design for the intended population. Diverse
patient groups may have different technology comfort
levels, and design will need to be adapted accordingly.
One area of design that has been developed in the litera-
ture pertains to modification of measurements for elec-
tronic delivery [9]. The level of modification needed for
translation from paper to electronic version will determine
the evidence needed to test measurement equivalence.
A limitation of this study is that the primary purpose
of the overarching project related to the feasibility of
ePROs in clinical settings [14] and not on issues that
emerged in the use of the technology; thus, systematic
questionnaires were not used to identify such issues.
Nevertheless, this paper is a form of knowledge transla-
tion offered to researchers/clinicians who will use ePROs
in future work. This study was only conducted in one
health authority and in one country, limiting the breadth
of issues encountered.
Although use of mobile devices, specifically tablet
computers, for data collection has many benefits, it also
poses new challenges for researchers. Advance consider-
ation of possible issues that emerge in the process, and
strategies to address these issues, may prevent disruption
and enhance validity of findings.
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